196 related articles for article (PubMed ID: 38150184)
1. Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis.
Saygin C; Zhang P; Stauber J; Aldoss I; Sperling AS; Weeks LD; Luskin MR; Knepper TC; Wanjari P; Wang P; Lager AM; Fitzpatrick C; Segal JP; Gharghabi M; Gurbuxani S; Venkataraman G; Cheng JX; Eisfelder BJ; Bohorquez O; Patel AA; Umesh Nagalakshmi S; Jayaram S; Odenike OM; Larson RA; Godley LA; Arber DA; Gibson CJ; Munshi NC; Marcucci G; Ebert BL; Greally JM; Steidl U; Lapalombella R; Shah BD; Stock W
Blood Cancer Discov; 2024 May; 5(3):164-179. PubMed ID: 38150184
[TBL] [Abstract][Full Text] [Related]
2. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis.
Saiki R; Ogawa S
Blood Cancer Discov; 2023 Mar; 4(2):102-105. PubMed ID: 36779909
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis.
Thol F; Klesse S; Köhler L; Gabdoulline R; Kloos A; Liebich A; Wichmann M; Chaturvedi A; Fabisch J; Gaidzik VI; Paschka P; Bullinger L; Bug G; Serve H; Göhring G; Schlegelberger B; Lübbert M; Kirchner H; Wattad M; Kraemer D; Hertenstein B; Heil G; Fiedler W; Krauter J; Schlenk RF; Döhner K; Döhner H; Ganser A; Heuser M
Leukemia; 2017 Jun; 31(6):1286-1295. PubMed ID: 27881874
[TBL] [Abstract][Full Text] [Related]
4. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
[TBL] [Abstract][Full Text] [Related]
5. [Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with NPM1 mutated acute myeloid leukemia after chemotherapy].
Wang LL; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):845-850. PubMed ID: 38049337
[No Abstract] [Full Text] [Related]
6. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
Steensma DP
Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
[TBL] [Abstract][Full Text] [Related]
7. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.
Kim R; Bergugnat H; Larcher L; Duchmann M; Passet M; Gachet S; Cuccuini W; Lafage-Pochitaloff M; Pastoret C; Grardel N; Asnafi V; Schäfer BW; Delabesse E; Itzykson R; Adès L; Hicheri Y; Chalandon Y; Graux C; Chevallier P; Hunault M; Leguay T; Huguet F; Lhéritier V; Dombret H; Soulier J; Rousselot P; Boissel N; Clappier E
Blood Cancer Discov; 2023 Mar; 4(2):134-149. PubMed ID: 36630200
[TBL] [Abstract][Full Text] [Related]
8. Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events.
Sant'Antonio E; Camerini C; Rizzo V; Musolino C; Allegra A
Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):573-579. PubMed ID: 34078586
[TBL] [Abstract][Full Text] [Related]
9. Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors.
Hong W; Li A; Liu Y; Xiao X; Christiani DC; Hung RJ; McKay J; Field J; Amos CI; Cheng C
Cancer Res; 2022 Jan; 82(2):199-209. PubMed ID: 34815255
[TBL] [Abstract][Full Text] [Related]
10. Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Bolton KL; Ptashkin RN; Gao T; Braunstein L; Devlin SM; Kelly D; Patel M; Berthon A; Syed A; Yabe M; Coombs CC; Caltabellotta NM; Walsh M; Offit K; Stadler Z; Mandelker D; Schulman J; Patel A; Philip J; Bernard E; Gundem G; Ossa JEA; Levine M; Martinez JSM; Farnoud N; Glodzik D; Li S; Robson ME; Lee C; Pharoah PDP; Stopsack KH; Spitzer B; Mantha S; Fagin J; Boucai L; Gibson CJ; Ebert BL; Young AL; Druley T; Takahashi K; Gillis N; Ball M; Padron E; Hyman DM; Baselga J; Norton L; Gardos S; Klimek VM; Scher H; Bajorin D; Paraiso E; Benayed R; Arcila ME; Ladanyi M; Solit DB; Berger MF; Tallman M; Garcia-Closas M; Chatterjee N; Diaz LA; Levine RL; Morton LM; Zehir A; Papaemmanuil E
Nat Genet; 2020 Nov; 52(11):1219-1226. PubMed ID: 33106634
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.
Cheng S; Zhang W; Inghirami G; Tam W
Elife; 2021 Sep; 10():. PubMed ID: 34581268
[TBL] [Abstract][Full Text] [Related]
12. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
13. [TFH lymphoma and associated clonal hematopoiesis].
Nann D; Fend F; Quintanilla-Martinez L
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):144-149. PubMed ID: 37870568
[TBL] [Abstract][Full Text] [Related]
14. Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia.
Tanaka T; Morita K; Loghavi S; Wang F; Furudate K; Sasaki Y; Little L; Gumbs C; Matthews J; Daver N; Pemmaraju N; DiNardo CD; Sasaki K; Yilmaz M; Kadia TM; Ravandi F; Konopleva MY; Kantarjian HM; Champlin RE; Al-Atrash G; Garcia-Manero G; Wang SA; Futreal PA; Takahashi K
Blood; 2021 Nov; 138(18):1733-1739. PubMed ID: 34115096
[TBL] [Abstract][Full Text] [Related]
15. [Clonal heterogeneity and its prognostic significance in acute lymphoblastic leukemia].
Lyu XD; Guo Z; Li YW; Hu JY; Fan RH; Song YP
Zhonghua Nei Ke Za Zhi; 2020 Aug; 59(8):629-633. PubMed ID: 34865381
[No Abstract] [Full Text] [Related]
16. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
[TBL] [Abstract][Full Text] [Related]
17. "Myeloid" Mutations in ALL Are Not Uncommon: Implications for Etiology and Therapies.
Iacobucci I
Blood Cancer Discov; 2024 May; 5(3):142-145. PubMed ID: 38689559
[TBL] [Abstract][Full Text] [Related]
18. Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.
Pegliasco J; Hirsch P; Marzac C; Isnard F; Meniane JC; Deswarte C; Pellet P; Lemaitre C; Leroy G; Rabadan Moraes G; Guermouche H; Schmaltz-Panneau B; Pasquier F; Colas C; Benusiglio PR; Bera O; Bourhis JH; Brissot E; Caron O; Chraibi S; Cony-Makhoul P; Delaunay-Darivon C; Lapusan S; de Fontbrune FS; Fuseau P; Najman A; Vainchenker W; Delhommeau F; Micol JB; Plo I; Bellanné-Chantelot C
Leukemia; 2022 Jan; 36(1):126-137. PubMed ID: 34172895
[TBL] [Abstract][Full Text] [Related]
19. The crossroads of cancer therapies and clonal hematopoiesis.
Singh A; Balasubramanian S
Semin Hematol; 2024 Feb; 61(1):16-21. PubMed ID: 38403501
[TBL] [Abstract][Full Text] [Related]
20. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
De Benedittis C; Papayannidis C; Venturi C; Abbenante MC; Paolini S; Parisi S; Sartor C; Cavo M; Martinelli G; Soverini S
BMC Cancer; 2017 Aug; 17(1):523. PubMed ID: 28779753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
